
Rayonier Advanced Materials Reports Q3 2025 Results

I'm PortAI, I can summarize articles.
Rayonier Advanced Materials (RYAM) reported its Q3 2025 results, showing net sales of $353 million and a reduced loss of $4 million. The Cellulose Specialties segment faced a 12% sales decline but improved operating income by 7%. Adjusted EBITDA was $42 million, with total debt at $794 million. The company anticipates annual adjusted EBITDA of $135-$140 million and aims to double EBITDA in two years. Rayonier is focused on cash management and strategic opportunities in Biomaterials, targeting over $300 million in run-rate EBITDA by 2027.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

